Intellia Therapeutics, Inc. (NTLA) Buy Rating Reiterated Despite Share Offering Dilution
Intellia Therapeutics, Inc. (NASDAQ: NTLA ) is one of the most shorted mid-cap and small-cap stocks to buy now . On May 13, H.C. Wainwright reiterated Intellia Therapeutics (NASDAQ:NTLA) as a Buy butโฆ
Yahoo Finance โ 5 June 2026
Text:
7
0
0
Intellia Therapeutics, Inc. (NASDAQ: NTLA ) is one of the most shorted mid-cap and small-cap stocks to buy now . On May 13, H.C. Wainwright reiterated
Read Full Story at Yahoo Finance โ Sources

